Atlas Trials

A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study

Clinical trial NCT06801379 · UNKNOWN

Trial details

NCT number
NCT06801379
Sponsor
Woolcock Institute of Medical Research
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Insomnia
Start date
2025-07-01
Primary completion
2025-12-31
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.